These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28001064)

  • 1. Recent Advances in Scaffold Hopping.
    Hu Y; Stumpfe D; Bajorath J
    J Med Chem; 2017 Feb; 60(4):1238-1246. PubMed ID: 28001064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
    Dimova D; Bajorath J
    Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic assessment of scaffold distances in ChEMBL: prioritization of compound data sets for scaffold hopping analysis in virtual screening.
    Li R; Bajorath J
    J Comput Aided Mol Des; 2012 Oct; 26(10):1101-9. PubMed ID: 22972561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a Structurally Novel Multipotent Drug Candidate by the Scaffold Architecture Technique for ACE-II, NSP15, and M
    Pakrashy S; Mandal PK; Dey SK; Choudhury SM; Alasmary FA; Almalki AS; Islam MA; Dolai M
    ACS Omega; 2022 Sep; 7(37):33408-33422. PubMed ID: 36157758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Exploration of Molecular Scaffolds in Medicinal Chemistry.
    Hu Y; Stumpfe D; Bajorath J
    J Med Chem; 2016 May; 59(9):4062-76. PubMed ID: 26840095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On scaffolds and hopping in medicinal chemistry.
    Brown N; Jacoby E
    Mini Rev Med Chem; 2006 Nov; 6(11):1217-29. PubMed ID: 17100633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of the Pharmacophore Concept in Natural Product inspired Drug Design.
    Seidel T; Wieder O; Garon A; Langer T
    Mol Inform; 2020 Nov; 39(11):e2000059. PubMed ID: 32578959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic assessment of scaffold hopping versus activity cliff formation across bioactive compound classes following a molecular hierarchy.
    Stumpfe D; Dimova D; Bajorath J
    Bioorg Med Chem; 2015 Jul; 23(13):3183-91. PubMed ID: 25982076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation.
    Krueger BA; Dietrich A; Baringhaus KH; Schneider G
    Comb Chem High Throughput Screen; 2009 May; 12(4):383-96. PubMed ID: 19442066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free energy perturbation (FEP)-guided scaffold hopping.
    Wu D; Zheng X; Liu R; Li Z; Jiang Z; Zhou Q; Huang Y; Wu XN; Zhang C; Huang YY; Luo HB
    Acta Pharm Sin B; 2022 Mar; 12(3):1351-1362. PubMed ID: 35530128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening.
    Vogt M; Stumpfe D; Geppert H; Bajorath J
    J Med Chem; 2010 Aug; 53(15):5707-15. PubMed ID: 20684607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the scaffold universe of kinase inhibitors.
    Hu Y; Bajorath J
    J Med Chem; 2015 Jan; 58(1):315-32. PubMed ID: 25192260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Scaffold Diversity of Kinase Inhibitors Using Alternative Scaffold Concepts and Estimating the Scaffold Hopping Potential for Different Kinases.
    Dimova D; Bajorath J
    Molecules; 2017 May; 22(5):. PubMed ID: 28467353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold hopping in drug discovery using inductive logic programming.
    Tsunoyama K; Amini A; Sternberg MJ; Muggleton SH
    J Chem Inf Model; 2008 May; 48(5):949-57. PubMed ID: 18457387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is scaffold hopping a reliable indicator for the ability of computational methods to identify structurally diverse active compounds?
    Dimova D; Bajorath J
    J Comput Aided Mol Des; 2017 Jul; 31(7):603-608. PubMed ID: 28623485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of scaffold-hopping approaches.
    Sun H; Tawa G; Wallqvist A
    Drug Discov Today; 2012 Apr; 17(7-8):310-24. PubMed ID: 22056715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrochemical lead optimization by scaffold hopping.
    Lamberth C
    Pest Manag Sci; 2018 Feb; 74(2):282-292. PubMed ID: 28991418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design.
    Seidel T; Schuetz DA; Garon A; Langer T
    Prog Chem Org Nat Prod; 2019; 110():99-141. PubMed ID: 31621012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.